Vertex passes key test in quest to treat kidney diseases

107347177 17024876422019 10 23t192640z 180367507 rc14151b5800 rtrmadp 0 vertex pharms fda

A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston. Brian Snyder | Reuters Vertex Pharmaceuticals said its experimental drug for a rare kidney condition succeeded in a Phase 3 trial, a crucial step in the company’s path to diversify beyond its main drugs for cystic fibrosis.  The Boston-based drugmaker on …

Read more